Naturally Splendid Responds to Health Canada’s Information Request Notice

Vancouver, British Columbia – TheNewswire – October 16, 2020 – Naturally Splendid Enterprises Ltd. (“Naturally Splendid”, “NSE” or “the Company”) (FRANKFURT:50N) (TSXV:NSP) (OTC:NSPDF) has responded through their joint venture Plasm Pharmaceutical (“Plasm”) to Health Canada’s Information Request Notice (“IRN”). The questions as posed by Health Canada are considered a formality as Plasm Pharmaceutical, continues to prepare for aContinue reading “Naturally Splendid Responds to Health Canada’s Information Request Notice”

Naturally Splendid Launches New Corporate Website and Provides Strategic Update

VANCOUVER, British Columbia – TheNewswire – October 5, 2020 — Naturally Splendid Enterprises Ltd. (“Naturally Splendid”) (TSXV:NSP) (OTC:NSPDF) (Frankfurt:50N) is pleased to announce the new Corporate website is now live at www.naturallysplendid.com. In addition to the new Corporate website, the Company will be systematically updating the individual Company brand websites to enhance consumer experience and improve the e-commerce procedure andContinue reading “Naturally Splendid Launches New Corporate Website and Provides Strategic Update”

Naturally Splendid Closes Private Placement, Secures Laboratory Facility

— Naturally Splendid Enterprises Ltd. (“Naturally Splendid”) (TSXV:NSP) (OTC:NSPDF) (Frankfurt:50N) is pleased to announce that it has closed its non-brokered private placement financing for a total of 15,887,503 units (the “Units”) at $0.06 per Unit, for total gross proceeds of $1,053,250 (the “Offering”). Due to oversubscribed demand, the private placement financing was increased from 14,166,667 Units to 17,554,167.Continue reading “Naturally Splendid Closes Private Placement, Secures Laboratory Facility”

Naturally Splendid Announces Biologic Definitive Agreement and Private Placement

“We continue to make progress on several fronts including significant steps towards beginning a phase 2 clinical trial for a potential COVID-19 treatment.” Founder & CEO Craig Goodwin Vancouver, British Columbia – The Newswire – September 2, 2020 – Naturally Splendid Enterprises Ltd. (“Naturally Splendid”, “NSE” or “the Company”) (FRANKFURT:50N) (TSXV:NSP) (OTC:NSPDF) is pleased to announceContinue reading “Naturally Splendid Announces Biologic Definitive Agreement and Private Placement”

Naturally Splendid Reports First Quarter Results for 2020

“Covid-19 appears to be accelerating the growth trend for plant-based nutrition even though this category was already out performing practically every other retail market food category.” HIGHLIGHTS Naturally Splendid recorded a net loss and comprehensive loss of $1,320,761 for the three months ended March 31, 2020 Revenues decreased slightly by 7% over the same periodContinue reading “Naturally Splendid Reports First Quarter Results for 2020”

Naturally Splendid Provides Clinical Trial Application Update

Naturally Splendid Enterprises Ltd.  (TSXV:NSP) (OTC:NSPDF) (Frankfurt:50N) provides the following update in regards to the Phase 2 Clinical Trial Application with Health Canada for a potential COVID-19 treatment. As an update to the Clinical Trial Application (CTA) process with Health Canada: A CTA was approved for submission to Health Canada on May 17, 2020. The HealthContinue reading “Naturally Splendid Provides Clinical Trial Application Update”

Naturally Splendid Provides 2019 in Review and 2020 Outlook

— Naturally Splendid Enterprises Ltd. (“Naturally Splendid”) (TSXV:NSP) (OTC:NSPDF) (Frankfurt:50N) announces its audited financial results for the year ended December 31, 2019. All amounts are in Canadian dollars and are prepared in accordance with International Financial Reporting Standards. Naturally Splendid recorded a net loss and comprehensive loss for the year of $7,030,070 during the year ended December 31,Continue reading “Naturally Splendid Provides 2019 in Review and 2020 Outlook”

Naturally Splendid Announces Inventory Produced for Target Drug, Cavaltinib(TM) for Phase 2 COVID 19 Clinical Trial

Vancouver, British Columbia – TheNewswire – June 1, 2020 – Naturally Splendid Enterprises Ltd. (“Naturally Splendid”, “NSE” or “the Company”) (FRANKFURT:50N) (TSXV:NSP) (OTC:NSPDF) is pleased to provide the following progress update for a Phase 2 clinical trial treatment for COVID 19. The Company is now awaiting notification by Health Canada to proceed to the Phase 2 clinical trial stage,Continue reading “Naturally Splendid Announces Inventory Produced for Target Drug, Cavaltinib(TM) for Phase 2 COVID 19 Clinical Trial”

Naturally Splendid Signs Sales Distribution Agreement with Ecotrend Ecologics

Vancouver, British Columbia – TheNewswire – May 6, 2020 – Naturally Splendid Enterprises Ltd. (“Naturally Splendid”, “NSE” or “the Company”) (FRANKFURT:50N) (TSXV:NSP) (OTC:NSPDF) announces the Company has signed a Sales Distribution Agreement with Vancouver based Ecotrend Ecologics (“Ecotrend”), to market certain Company Brands across Canada. The first product that Ecotrend will market and distribute for Naturally Splendid, is theContinue reading “Naturally Splendid Signs Sales Distribution Agreement with Ecotrend Ecologics”